The emerging role of neoadjuvant chemotherapy for rectal cancer

Por Boland, Patrick M., Fakih, Marwan
Publicado em 2014

Immunotherapy for Colorectal Cancer

Por Boland, Patrick M., Ma, Wen Wee
Publicado no Cancers (Basel) (2017)

Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas

Por Smaglo, Brandon G., Tesfaye, Anteneh, Halfdanarson, Thorvardur R., Meyer, Joshua E., Wang, Jue, Gatalica, Zoran, Reddy, Sandeep, Arguello, David, Boland, Patrick M.
Publicado no Oncotarget (2015)

Topoisomerase I (Top1): a major target of FL118 for its antitumor efficacy or mainly involved in its side effects of hematopoietic toxicity?

Por Li, Fengzhi, Ling, Xiang, Harris, Danni L, Liao, Jianqun, Wang, Yuping, Westover, David, Jiang, Guohui, Xu, Bo, Boland, Patrick M, Jin, Chunyang
Publicado no Am J Cancer Res (2017)

Molecular profiling of neuroendocrine malignancies to identify prognostic and therapeutic markers: a Fox Chase Cancer Center Pilot Study

Por Vijayvergia, Namrata, Boland, Patrick M, Handorf, Elizabeth, Gustafson, Karen S, Gong, Yulan, Cooper, Harry S, Sheriff, Fathima, Astsaturov, Igor, Cohen, Steven J, Engstrom, Paul F
Publicado no Br J Cancer (2016)

Induction therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil and Radiotherapy Followed...

Por Boland, Patrick M, Meyer, Joshua E, Berger, Adam C, Cohen, Steven J, Neuman, Tzahi, Cooper, Harry S, Olszanski, Anthony J, Davey, Monica, Cheng, Jonathan D, Lebenthal, Abraham, Burtness, Barbara A, Scott, Walter J, Astsaturov, Igor A
Publicado no Am J Clin Oncol (2017)